ACTG 076 and reduction of perinatal transmission.
D000293:Adolescent; D000328:Adult; D001741:Black or African American; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use* / Q000633:toxicity; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission*; D006630:Hispanic or Latino; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D018580:Mandatory Testing / Q000331:legislation & jurisprudence; D051379:Mice; D009316:National Institutes of Health (U.S.); D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D014481:United States / Q000453:epidemiology; D014492:United States Public Health Service; D015215:Zidovudine / Q000627:therapeutic use* / Q000633:toxicity
D019380:Anti-HIV Agents; D015215:Zidovudine